Literature DB >> 7499251

Two residues that may ligate Ca2+ in transmembrane domain six of the plasma membrane Ca(2+)-ATPase.

A O Adebayo1, A Enyedi, A K Verma, A G Filoteo, J T Penniston.   

Abstract

In order to identify Ca2+ ligands in the putative transmembrane domain 6 of the plasma membrane Ca2+ pump, amino acids Asn879, Met882, Asp883, and Ser887 were singly altered. Asn879, Met882, and Asp883 were chosen because the corresponding amino acids have been proposed as Ca2+ ligands in the sarcoplasmic reticulum Ca2+ pump (Clarke, D. M., Loo, T. W., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 6262-6267). For the alterations, a fully active truncated version of the pump was used, because the interaction of Ca2+ with the pump could be studied without interference from calmodulin binding. The mutants at Asn and Asp did not carry out ATP-supported Ca2+ uptake and formed no acylphosphate from [gamma-32P]ATP, suggesting that, like the corresponding amino acids in the sarcoplasmic reticulum Ca2+ pump, these two are Ca2+ ligands. However, all the mutants at the position of Met882 showed some activity. Indeed, the Met882--> Ile mutant was fully active at a saturating Ca2+ concentration and only the K1/2 for Ca2+ activation was shifted slightly upward. Converting the Met to Thr (which is the corresponding residue in the sarcoplasmic reticulum Ca2+ pump) reduced the activity to 20% of the wild type, further emphasizing the differences between the two Ca2+ pumps. The mutant Ser887--> Ala was expressed in greater amounts than, and had a specific activity about 50% higher than, the wild type, indicating that this serine also could not be a Ca2+ ligand and could not replace the missing Thr at position Met882.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499251     DOI: 10.1074/jbc.270.46.27812

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Constitutive activation of gastric H+,K+-ATPase by a single mutation.

Authors:  H G Swarts; H P Hermsen; J B Koenderink; F M Schuurmans Stekhoven; J J De Pont
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

2.  The novel mouse mutation Oblivion inactivates the PMCA2 pump and causes progressive hearing loss.

Authors:  Sarah L Spiden; Mario Bortolozzi; Francesca Di Leva; Martin Hrabé de Angelis; Helmut Fuchs; Dmitry Lim; Saida Ortolano; Neil J Ingham; Marisa Brini; Ernesto Carafoli; Fabio Mammano; Karen P Steel
Journal:  PLoS Genet       Date:  2008-10-31       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.